Africa’s biggest drugmaker sees move to vaccine autonomy
The need to speed up local vaccine production remains pressing Aspen’s Gqeberha facility, already filling vials, may expand Africa’s plans to increase vaccine autonomy are gaining traction as the continent seeks to reduce its dependence on foreign companies that supply about 80% of the drugs and 99% of the vaccines used in the region, according … Continue reading Africa’s biggest drugmaker sees move to vaccine autonomy
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed